Publication date: Available online 26 October 2026 Source: Journal of Thrombosis and Haemostasis Author(s): Hong Tian, Xuewen Song, Yueting Huang, Lu Zhou, Ruinan Lu, Lili Ji, Yun Li, Haiju He, Ziqiang Yu, Hu Zhou, Jie Yin
Combination of Thrombopoietin Receptor Agonists and Rituximab in Relapsed/Refractory Immune Thrombocytopenia: A Multicenter Real-World Study. // Journal of Thrombosis and Haemostasis. – URL: https://www.sciencedirect.com/science/article/pii/S153878362600680X?dgcid=rss_sd_all
Combination of Thrombopoietin Receptor Agonists and Rituximab in Relapsed/Refractory Immune Thrombocytopenia: A Multicenter Real-World Study. Journal of Thrombosis and Haemostasis. https://www.sciencedirect.com/science/article/pii/S153878362600680X?dgcid=rss_sd_all
“Combination of Thrombopoietin Receptor Agonists and Rituximab in Relapsed/Refractory Immune Thrombocytopenia: A Multicenter Real-World Study.” Journal of Thrombosis and Haemostasis.
@article{article90001,
title = {Combination of Thrombopoietin Receptor Agonists and Rituximab in Relapsed/Refractory Immune Thrombocytopenia: A Multicenter Real-World Study},
journal = {Journal of Thrombosis and Haemostasis},
url = {https://www.sciencedirect.com/science/article/pii/S153878362600680X?dgcid=rss_sd_all}
}